Hans-Peter Brunner-La Rocca
Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF
Simonavičius J, Maeder M, Eurlings C, Aizpurua A, Čelutkienė J, Barysienė J, Toggweiler S, Kaufmann B, Brunner-La Rocca H. Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF. Clin Res Cardiol 2020
20.11.2020Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF
20.11.2020Clin Res Cardiol 2020
Simonavičius Justas, Maeder Micha, Eurlings Casper G M J, Aizpurua Arantxa Barandiarán, Čelutkienė Jelena, Barysienė Jūratė, Toggweiler Stefan, Kaufmann Beat A, Brunner-La Rocca Hans-Peter
Polygenic Score for Beta-Blocker Survival Benefit in European Ancestry Patients with Reduced Ejection Fraction Heart Failure
Lanfear D, Li J, Brunner-La Rocca H, Kraus W, Sabbah H, Maeder M, Zeld N, Sanders-van Wijk S, Adams K, O'Connor C, Donahue M, Gui H, She R, Luzum J, Williams L. Polygenic Score for Beta-Blocker Survival Benefit in European Ancestry Patients with Reduced Ejection Fraction Heart Failure. Circ Heart Fail 2020
04.10.2020Polygenic Score for Beta-Blocker Survival Benefit in European Ancestry Patients with Reduced Ejection Fraction Heart Failure
04.10.2020Circ Heart Fail 2020
Lanfear David E, Li Jia, Brunner-La Rocca Hans-Peter, Kraus William E, Sabbah Hani N, Maeder Micha, Zeld Nicole, Sanders-van Wijk Sandra, Adams Kirkwood F, O'Connor Christopher M, Donahue Mark P, Gui Hongsheng, She Ruicong, Luzum Jasmine A, Williams L Keoki
Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial
Stöhr R, Sanders-van Wijk S, Pfisterer M, Jeker U, Schuh A, Leibundgut G, Maeder M, Heine G, Brandenburg V, Brunner-La Rocca H. Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial. Eur J Heart Fail 2020
05.02.2020Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial
05.02.2020Eur J Heart Fail 2020
Stöhr Robert, Sanders-van Wijk Sandra, Pfisterer Matthias, Jeker Urs, Schuh Alexander, Leibundgut Gregor, Maeder Micha, Heine Gunnar H, Brandenburg Vincent M, Brunner-La Rocca Hans-Peter
Prognostic Significance of Longitudinal Clinical Congestion Pattern in Chronic Heart Failure: Insights From TIME-CHF Trial
Simonavičius J, van Empel V, Knackstedt C, Puronaitė R, Čelutkienė J, Pfisterer M, Kaufmann B, Pfister O, Maeder M, Rickenbacher P, Sanders van-Wijk S, Brunner-La Rocca H. Prognostic Significance of Longitudinal Clinical Congestion Pattern in Chronic Heart Failure: Insights From TIME-CHF Trial. Am J Med 2019; 132:e679-e692.
30.04.2019Prognostic Significance of Longitudinal Clinical Congestion Pattern in Chronic Heart Failure: Insights From TIME-CHF Trial
30.04.2019Am J Med 2019; 132:e679-e692
Simonavičius Justas, van Empel Vanessa, Knackstedt Christian, Puronaitė Roma, Čelutkienė Jelena, Pfisterer Matthias, Kaufmann Beat A, Pfister Otmar, Maeder Micha, Rickenbacher Peter, Sanders van-Wijk Sandra, Brunner-La Rocca Hans-Peter
Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?
Steinmann E, Brunner-La Rocca H, Maeder M, Kaufmann B, Pfisterer M, Rickenbacher P. Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?. Eur J Intern Med 2018
13.06.2018Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?
13.06.2018Eur J Intern Med 2018
Steinmann Eva, Brunner-La Rocca Hans-Peter, Maeder Micha, Kaufmann Beat A, Pfisterer Matthias, Rickenbacher Peter
Novel concept to guide systolic heart failure medication by repeated biomarker testing-results from TIME-CHF in context of predictive, preventive, and personalized medicine
Davarzani N, Brunner-La Rocca H, Peeters R, Pfisterer M, Zaugg C, Rolny V, Block D, de Boer R, Suter T, Karel J, Smirnov E, Rickenbacher P, Maeder M, Sanders-van Wijk S, TIME-CHF Investigators. Novel concept to guide systolic heart failure medication by repeated biomarker testing-results from TIME-CHF in context of predictive, preventive, and personalized medicine. EPMA J 2018; 9:161-173.
13.05.2018Novel concept to guide systolic heart failure medication by repeated biomarker testing-results from TIME-CHF in context of predictive, preventive, and personalized medicine
13.05.2018EPMA J 2018; 9:161-173
Davarzani Nasser, Brunner-La Rocca Hans-Peter, Peeters Ralf, Pfisterer Matthias E, Zaugg Christian, Rolny Vinzent, Block Dirk, de Boer Rudolf A, Suter Thomas, Karel Joël, Smirnov Evgueni, Rickenbacher Peter, Maeder Micha, Sanders-van Wijk Sandra, TIME-CHF Investigators
Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)
Rickenbacher P, Kaufmann B, Maeder M, Bernheim A, Goetschalckx K, Pfister O, Pfisterer M, Brunner-La Rocca H. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Eur J Heart Fail 2017
15.03.2017Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)
15.03.2017Eur J Heart Fail 2017
Rickenbacher Peter, Kaufmann Beat A, Maeder Micha, Bernheim Alain, Goetschalckx Kaatje, Pfister Otmar, Pfisterer Matthias, Brunner-La Rocca Hans-Peter
N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF
Davarzani N, Peeters R, Rickenbacher P, Pfisterer M, Gutmann M, Leibundgut G, Maeder M, Karel J, Sanders-van Wijk S, Brunner-La Rocca H. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF. J Card Fail 2017; 23:382-389.
13.02.2017N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF
13.02.2017J Card Fail 2017; 23:382-389
Davarzani Nasser, Peeters Ralf, Rickenbacher Peter, Pfisterer Matthias E, Gutmann Marc, Leibundgut Gregor, Maeder Micha, Karel Joël, Sanders-van Wijk Sandra, Brunner-La Rocca Hans-Peter
Predicting hospitalization and mortality in patients with heart failure: The BARDICHE-index
Uszko-Lencer N, Brunner-La Rocca H, Zugck C, Pfisterer M, Osswald S, Muzzarelli S, Gutmann M, Maeder M, Spruit M, Frankenstein L. Predicting hospitalization and mortality in patients with heart failure: The BARDICHE-index. Int J Cardiol 2016; 227:901-907.
09.11.2016Predicting hospitalization and mortality in patients with heart failure: The BARDICHE-index
09.11.2016Int J Cardiol 2016; 227:901-907
Uszko-Lencer Nicole H M K, Brunner-La Rocca Hans-Peter, Zugck Christian, Pfisterer Matthias E, Osswald Stefan, Muzzarelli Stefano, Gutmann Marc, Maeder Micha, Spruit Martijn A, Frankenstein Lutz
Prognostic Value of the Change in Heart Rate From the Supine to the Upright Position in Patients With Chronic Heart Failure
Maeder M, Brunner-La Rocca H, Pfisterer M, Julius B, Yoon S, Suter T, Kiencke S, Tobler D, Rickli H, Zurek M. Prognostic Value of the Change in Heart Rate From the Supine to the Upright Position in Patients With Chronic Heart Failure. J Am Heart Assoc 2016; 5
08.08.2016Prognostic Value of the Change in Heart Rate From the Supine to the Upright Position in Patients With Chronic Heart Failure
08.08.2016J Am Heart Assoc 2016; 5
Maeder Micha, Brunner-La Rocca Hans-Peter, Pfisterer Matthias E, Julius Barbara, Yoon Se-Il, Suter Thomas, Kiencke Stephanie, Tobler Daniel, Rickli Hans, Zurek Marzena
Differential Prognostic Impact of Resting Heart Rate in Older Compared to Younger Patients with Chronic Heart Failure - Insights from TIME-CHF
Zurek M, Brunner-La Rocca H, Pfisterer M, Jeker U, Handschin R, Abbühl H, Sanders-van Wijk S, Muzzarelli S, Rickli H, Maeder M, TIME-CHF Investigators. Differential Prognostic Impact of Resting Heart Rate in Older Compared to Younger Patients with Chronic Heart Failure - Insights from TIME-CHF. J Card Fail 2015
07.01.2015Differential Prognostic Impact of Resting Heart Rate in Older Compared to Younger Patients with Chronic Heart Failure - Insights from TIME-CHF
07.01.2015J Card Fail 2015
Zurek Marzena, Brunner-La Rocca Hans-Peter, Pfisterer Matthias, Jeker Urs, Handschin Rolf, Abbühl Heidi, Sanders-van Wijk Sandra, Muzzarelli Stefano, Rickli Hans, Maeder Micha, TIME-CHF Investigators
Impact of worsening renal function related to medication in heart failure
Brunner-La Rocca H, Maeder M, Rickenbacher P, Tobler D, Pfisterer M, Krause F, Rolny V, Eurlings L, Knackstedt C, TIME‐CHF investigators. Impact of worsening renal function related to medication in heart failure. Eur J Heart Fail 2014; 17:159-68.
30.12.2014Impact of worsening renal function related to medication in heart failure
30.12.2014Eur J Heart Fail 2014; 17:159-68
Brunner-La Rocca Hans-Peter, Maeder Micha, Rickenbacher Peter, Tobler Daniel, Pfisterer Matthias E, Krause Friedemann, Rolny Vinzent, Eurlings Luc, Knackstedt Christian, TIME‐CHF investigators
Interaction between pulmonary hypertension and diastolic dysfunction in an elderly heart failure population
van Empel V, Maeder M, Kiencke S, Pfisterer M, Muzzarelli S, Min S, Goetschalckx K, Bernheim A, Kaufmann B, Brunner-La Rocca H. Interaction between pulmonary hypertension and diastolic dysfunction in an elderly heart failure population. J Card Fail 2013; 20:98-104.
18.12.2013Interaction between pulmonary hypertension and diastolic dysfunction in an elderly heart failure population
18.12.2013J Card Fail 2013; 20:98-104
van Empel Vanessa P M, Maeder Micha, Kiencke Stephanie, Pfisterer Matthias E, Muzzarelli Stefano, Min Son Y, Goetschalckx Kaatje, Bernheim Alain M, Kaufmann Beat A, Brunner-La Rocca Hans-Peter
Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF
Sanders-van Wijk S, Brunner-La Rocca H, Pfisterer M, Peter M, Rickenbacher P, Erne P, Estlinbaum W, Rickli H, Nietlispach F, Maeder M, TIME-CHF Investigators. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF. Circ Heart Fail 2013; 7:131-9.
18.12.2013Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF
18.12.2013Circ Heart Fail 2013; 7:131-9
Sanders-van Wijk Sandra, Brunner-La Rocca Hans-Peter, Pfisterer Matthias P, Peter Martin, Rickenbacher Peter, Erne Paul, Estlinbaum Werner, Rickli Hans, Nietlispach Fabian, Maeder Micha, TIME-CHF Investigators
N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF)
Maeder M, Brunner-La Rocca H, Pfisterer M, Peter M, Vuilliomenet A, Erne P, Gutmann M, Abbühl H, Rickli H, Rickenbacher P, TIME-CHF Investigators. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Eur J Heart Fail 2013; 15:1148-56.
08.05.2013N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF)
08.05.2013Eur J Heart Fail 2013; 15:1148-56
Maeder Micha, Brunner-La Rocca Hans-Peter, Pfisterer Matthias, Peter Martin, Vuilliomenet André, Erne Paul, Gutmann Marc, Abbühl Heidi, Rickli Hans, Rickenbacher Peter, TIME-CHF Investigators
Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial
Huijts M, Brunner-La Rocca H, Pfisterer M, Schindler R, Maeder M, Muzzarelli S, Burkard T, Duits A, van Oostenbrugge R, TIME-CHF Investigators. Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial. Eur J Heart Fail 2013; 15:699-707.
05.02.2013Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial
05.02.2013Eur J Heart Fail 2013; 15:699-707
Huijts Marjolein, Brunner-La Rocca Hans-Peter, Pfisterer Matthias E, Schindler Ruth, Maeder Micha, Muzzarelli Stefano, Burkard Thilo, Duits Annelien, van Oostenbrugge Robert J, TIME-CHF Investigators
Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure)
Sanders-van Wijk S, Brunner-La Rocca H, Pfisterer M, Peter M, Vuillomenet A, Rickenbacher P, Erne P, Estlinbaum W, Rickli H, van Asselt A, TIME-CHF Investigators. Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure). JACC Heart Fail 2013; 1:64-71.
04.02.2013Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure)
04.02.2013JACC Heart Fail 2013; 1:64-71
Sanders-van Wijk Sandra, Brunner-La Rocca Hans-Peter, Pfisterer Matthias E, Peter Martin, Vuillomenet André, Rickenbacher Peter, Erne Paul, Estlinbaum Werner, Rickli Hans, van Asselt Antoinette D I, TIME-CHF Investigators
Prognostic value of self-reported versus objectively measured functional capacity in patients with heart failure: results from the TIME-CHF (Trial of Intensified Versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure)
Spruit M, Brunner-La Rocca H, Rickli H, Pfisterer M, Kiencke S, Uszko-Lencer N, Jeker U, Ammann P, Knackstedt C, Maeder M, TIME-CHF Investigators. Prognostic value of self-reported versus objectively measured functional capacity in patients with heart failure: results from the TIME-CHF (Trial of Intensified Versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure). J Am Coll Cardiol 2012; 60:2125-6.
13.11.2012Prognostic value of self-reported versus objectively measured functional capacity in patients with heart failure: results from the TIME-CHF (Trial of Intensified Versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure)
13.11.2012J Am Coll Cardiol 2012; 60:2125-6
Spruit Martijn A, Brunner-La Rocca Hans-Peter, Rickli Hans, Pfisterer Matthias E, Kiencke Stephanie, Uszko-Lencer Nicole H M K, Jeker Urs, Ammann Peter, Knackstedt Christian, Maeder Micha, TIME-CHF Investigators
Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy
Maeder M, Brunner-La Rocca H, Estlinbaum W, Kiencke S, Dieterle T, Weilenmann D, Hack D, Fehr T, Ammann P, Muzzarelli S, Pfisterer M, Rickli H, TIME-CHF Investigators. Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy. Am Heart J 2012; 163:407-14, 414.e1.
01.03.2012Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy
01.03.2012Am Heart J 2012; 163:407-14, 414.e1
Maeder Micha, Brunner-La Rocca Hans-Peter, Estlinbaum Werner, Kiencke Stephanie, Dieterle Thomas, Weilenmann Daniel, Hack Dietrich, Fehr Thomas, Ammann Peter, Muzzarelli Stefano, Pfisterer Matthias E, Rickli Hans, TIME-CHF Investigators
Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy
Muzzarelli S, Brunner-La Rocca H, Pfisterer M, Burkard T, Julius B, Nietlispach F, Rickli H, Toggweiler S, Maeder M, TIME-CHF Investigators. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy. Am J Cardiol 2011; 109:693-8.
05.12.2011Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy
05.12.2011Am J Cardiol 2011; 109:693-8
Muzzarelli Stefano, Brunner-La Rocca Hans-Peter, Pfisterer Matthias Emil, Burkard Thilo, Julius Barbara, Nietlispach Fabian, Rickli Hans, Toggweiler Stefan, Maeder Micha, TIME-CHF Investigators